CoChat

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Severe, refractory obsessive-compulsive disorder (OCD) is a disabling condition. Stimulation of the subthalamic nucleus, a procedure that is already validated for the treatment of movement disorders, has been proposed as a therapeutic option. METHODS: In this 10-month, crossover, double-blind, multicenter study assessing the efficacy and safety of stimulation of the subthalamic nucleus, we randomly assigned eight patients with highly refractory OCD to undergo active stimulation of the subthalamic nucleus followed by sham stimulation and eight to undergo sham stimulation followed by active stimulation. The primary outcome measure was the severity of OCD, as assessed by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), at the end of two 3-month periods. General psychopathologic findings, functioning, and tolerance were assessed with the use of standardized psychiatric scales, the Global Assessment of Functioning (GAF) scale, and neuropsychological tests. RESULTS: After active stimulation of the subthalamic nucleus, the Y-BOCS score (on a scale from 0 to 40, with lower scores indicating less severe symptoms) was significantly lower than the score after sham stimulation (mean [+/-SD], 19+/-8 vs. 28+/-7; P=0.01), and the GAF score (on a scale from 1 to 90, with higher scores indicating higher levels of functioning) was significantly higher (56+/-14 vs. 43+/-8, P=0.005). The ratings of neuropsychological measures, depression, and anxiety were not modified by stimulation. There were 15 serious adverse events overall, including 1 intracerebral hemorrhage and 2 infections; there were also 23 nonserious adverse events. CONCLUSIONS: These preliminary findings suggest that stimulation of the subthalamic nucleus may reduce the symptoms of severe forms of OCD but is associated with a substantial risk of serious adverse events. (ClinicalTrials.gov number, NCT00169377.)

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa0708514

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 2

  1. Sheehan DV, 1998, J Clin Psychiatry, 59, 22
  2. Pillon B, Boller F, Levy R, Dubois B. Cognitive deficit and dementia in Parkinson's disease. In: Boller F, Cappa S, eds. Aging and dementia. Vol. 6 of Handbook of neuropsychology. 2nd ed. Amsterdam: Elsevier, 2001:311-72.

Cited by

See all 1,000

Metadata

Authors
Mallet, L., Polosan, M., Jaafari, N., Baup, N., Welter, M.-L., Fontaine, D., Montcel, S. T. D., Yelnik, J., Chéreau, I., Arbus, C., Raoul, S., Aouizerate, B., Damier, P., Chabardès, S., Czernecki, V., Ardouin, C., Krebs, M.-O., Bardinet, E., Chaynes, P., Burbaud, P., Cornu, P., Derost, P., Bougerol, T., Bataille, B., Mattei, V., Dormont, D., Devaux, B., Vérin, M., Houeto, J.-L., Pollak, P., Benabid, A.-L., Agid, Y., Krack, P., Millet, B., & Pelissolo, A.
Affiliations
  • Inserm (FR)
  • Centre Hospitalier Universitaire de Grenoble (FR)
  • Centre Hospitalier Universitaire de Nice (FR)
  • Université de Bordeaux (FR)
  • Fondation FondaMental (FR)
  • Pitié-Salpêtrière Hospital (FR)
  • Université Paris Descartes (FR)
  • Centre Hospitalier Universitaire de Rennes (FR)
  • Université Joseph Fourier (FR)
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
Venue
New England Journal of Medicine
Published
2008-11-13
Volume
359
Issue
20
Pages
2121-2134
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2161118302
Cited by
965
References
46
Citations by year
2026: 38 · 2025: 37 · 2024: 44 · 2023: 38 · 2022: 38 · 2021: 48 · 2020: 63 · 2019: 56 · 2018: 71 · 2017: 53 · 2016: 52 · 2015: 66 · 2014: 63 · 2013: 71 · 2012: 71
FWCI
55.94
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
subthalamic nucleus deep brain stimulation, deep brain stimulation, refractory obsessive-compulsive disorder, Yale-Brown Obsessive Compulsive Scale, Global Assessment of Functioning, adverse events, intracerebral hemorrhage, neuropsychological outcomes
MeSH terms
Adult, Cerebral Hemorrhage, Double-Blind Method, Electric Stimulation Therapy, Female, Humans, Infections, Male, Middle Aged, Obsessive-Compulsive Disorder, Cross-Over Studies, Subthalamic Nucleus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.